111 Inc (YI)
0.6539
-0.03
(-3.84%)
USD |
NASDAQ |
Nov 14, 16:00
0.6539
0.00 (0.00%)
After-Hours: 17:51
111 Gross Profit Margin (Quarterly): 6.06% for June 30, 2024
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 6.06% |
| March 31, 2024 | 5.91% |
| December 31, 2023 | 5.21% |
| September 30, 2023 | 5.20% |
| June 30, 2023 | 5.98% |
| March 31, 2023 | 6.39% |
| December 31, 2022 | 6.11% |
| September 30, 2022 | 6.03% |
| June 30, 2022 | 6.32% |
| March 31, 2022 | 6.46% |
| December 31, 2021 | 5.91% |
| September 30, 2021 | 4.96% |
| June 30, 2021 | 4.45% |
| March 31, 2021 | 4.46% |
| Date | Value |
|---|---|
| December 31, 2020 | 3.92% |
| September 30, 2020 | 3.81% |
| June 30, 2020 | 5.23% |
| March 31, 2020 | 5.56% |
| December 31, 2019 | 3.15% |
| September 30, 2019 | 4.26% |
| June 30, 2019 | 5.02% |
| March 31, 2019 | 5.07% |
| December 31, 2018 | 4.15% |
| September 30, 2018 | 3.13% |
| June 30, 2018 | 6.11% |
| March 31, 2018 | 12.45% |
| December 31, 2017 | 8.07% |
| September 30, 2017 | 10.02% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
3.15%
Minimum
Dec 2019
6.46%
Maximum
Mar 2022
5.32%
Average
5.56%
Median
Mar 2020
Gross Profit Margin (Quarterly) Benchmarks
| Dr Reddy's Laboratories Ltd | 59.59% |
| Concord Medical Services Holdings Ltd | -- |
| Sinovac Biotech Ltd | -- |
| CASI Pharmaceuticals Inc | 51.95% |
| Zai Lab Ltd | 64.94% |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | -94.37% |
| Return on Assets | -10.89% |
| Return on Invested Capital | -52.61% |
| Profit Margin (Quarterly) | -0.41% |
| Operating Margin (Quarterly) | 0.10% |
| Return on Net Operating Assets | -15.28% |